AstraZeneca PLC
30 April 2003
FOR IMMEDIATE RELEASE:
ASTRAZENECA PLC
ANNUAL GENERAL MEETING : 30 APRIL 2003
AstraZeneca PLC announced the results of the polls taken at its Annual General
Meeting today in respect of Items 5(e), 9 and 10 on the Agenda, as follows:
Item 5(e): Ordinary Resolution to re-elect Sir Peter Bonfield as a Director:
VOTES FOR: 830,994,339 (95.57%)
VOTES AGAINST: 38,475,456 (4.43%)
This Resolution was passed as an Ordinary Resolution at the AGM.
Percy Barnevik, Chairman of AstraZeneca PLC, said 'My Board colleagues and I are
delighted that Sir Peter Bonfield has been re-elected as a Director with such
overwhelming support following the poll held at today's Annual General Meeting.
Sir Peter is making a key contribution to AstraZeneca in his role both as the
senior Non-Executive Director and also as Chairman of the Remuneration
Committee.'
Item 9: Special Resolution to authorise the Directors to allot unissued shares:
VOTES FOR: 813,215,344 (95.90%)
VOTES AGAINST: 34,776,305 (4.10%)
This Resolution was passed as a Special Resolution at the AGM.
Item 10: Special Resolution to authorise the Company to purchase its own shares:
VOTES FOR: 890,748,684 (99.86%)
VOTES AGAINST: 1,261,770 (0.14%)
This Resolution was passed as a Special Resolution at the AGM.
Under the Company's Articles of Association, voting on all Special Resolutions
is conducted by poll.
G H R Musker
Company Secretary
30 April 2003
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.